Trial Profile
Treatment persistence in patients with atrial fibrillation treated with dabigatran etexilate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 01 Jul 2017 New trial record